Researchers discover “protective switches” that shield the coronavirus from immune system attacks

Over 700 million people were infected and almost seven million died, making SARS-CoV-2 the most devastating pandemic of the 21st century.

Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease – Biotech Investments

EQS-News: ABIVAX / Key word(s): Study Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease 02.02.2024 /

February 3, 2024

Lung cells can be trained to counteract inflammation

Inflammation is a standard part of our bodies’ immune system response. But sometimes this response becomes hyperactivated in our lungs, causing inflammation to continue unchecked,

August 24, 2023

Study links screen time to increased risk of manic symptoms in preteens

Preteens who spend more time on screens are more likely to develop manic symptoms years two-years later, according to a new study published in Social

February 20, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.